Transfection News and Research

RSS
Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Using virus-like particles to study SARS-CoV-2 assembly, budding, and entry

Furin cleavage site of SARS-CoV-2 spike glycoprotein enhances viral replication in the lungs

Furin cleavage site of SARS-CoV-2 spike glycoprotein enhances viral replication in the lungs

Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys

Clover Biopharma's new trimeric subunit vaccine candidate prevents COVID-19 in monkeys

Bacteria-free method for making SARS-CoV-2 infectious clones

Bacteria-free method for making SARS-CoV-2 infectious clones

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

S-pseudotyped VLPs offer promising COVID-19 vaccine platform

Effective, simple, safe self-amplifying RNA vaccines

Effective, simple, safe self-amplifying RNA vaccines

A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines

A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines

DeNovix launches 21 CFR Part 11 Compliance Ready software for CellDrop Automated Cell Counters

DeNovix launches 21 CFR Part 11 Compliance Ready software for CellDrop Automated Cell Counters

SARS-CoV-2 ORF9c responsible for immune evasion and efficient infection of host

SARS-CoV-2 ORF9c responsible for immune evasion and efficient infection of host

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

SARS-CoV-2 hijacks antiviral factors to promote infection in human lung cells

C-type lectin receptors play a role in SARS-CoV-2 infection

C-type lectin receptors play a role in SARS-CoV-2 infection

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Potential antibody treatment for yellow fever developed in 7 months using Rapid Response Strategy

Stabilized prefusion spike vaccine candidate induces powerful immune response

Stabilized prefusion spike vaccine candidate induces powerful immune response

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Basigin/CD147 discarded as an accessory SARS-CoV-2 binding receptor

Cat catches coronavirus from owners

Cat catches coronavirus from owners

Monash University researchers pave way for affordable immunotherapies

Monash University researchers pave way for affordable immunotherapies

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Game-Changer: A SARS-CoV-2 serological test for 50-cents per sample!

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Study identifies three novel broad-spectrum SARS-CoV-2 cell entry inhibitors

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

Novel vaccine platform against COVID-19 based on engineered human mesenchymal stem cells

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.